Poultry Vaccines Market Size, Share & Trends Analysis Report By Product (Attenuated Live Vaccines, Inactivated Vaccines, Recombinant Vaccines), By Disease Type, By Application, By Region, And Segment Forecasts, 2022 - 2030

Poultry Vaccines Market Size, Share & Trends Analysis Report By Product (Attenuated Live Vaccines, Inactivated Vaccines, Recombinant Vaccines), By Disease Type, By Application, By Region, And Segment Forecasts, 2022 - 2030

Poultry Vaccines Market Growth & Trends

The global poultry vaccines market size is expected to reach USD 3.39 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.1% from 2022 to 2030. The key factors driving the market include the rising consumption of poultry meat and eggs, the prevalence of avian diseases, and the increasing poultry population in key markets. According to OECD-FAO Agricultural Outlook, poultry meat consumption in the U.S. was pegged at 19,169 thousand tons in 2020. This consumption is projected to increase over the next few years.

The COVID-19 pandemic resulted in several challenges for the poultry industry including a fall in consumption, increased concerns over zoonoses, and low sales. For example, as per the Economic Times, in March 2020, the price of chicken plunged by as much as 70% due to the reduced consumption of meat, fish, eggs, and chicken. However, the pandemic also led to the rising awareness regarding diseases in animals and increasing demand for safe and healthy poultry products. This is anticipated to create opportunities for poultry vaccines manufacturers as poultry farms must ensure healthy layer, broiler, and breeder stock. In fact, in April 2021, the CEO & MD of Hester Biosciences Ltd. stated that the market for poultry vaccines is set to grow significantly post COVID.

In addition, the advent of new vaccines, such as Salmonella-vectored vaccines, which protect domesticated birds against necrotic enteritis is anticipated to provide a growth platform to this market. In addition, the rising usage of poultry vaccines by research institutes and colleges, along with vaccination awareness programs, is fueling the growth of the market. For instance, in July 2019, the Veterinary College and Research Institute based in Madurai, India started vaccinating domesticated birds, predominantly chickens, to save farmers from suffering significant losses.

Technological advancements in poultry vaccines, rising demand for animal protein, concerns over food safety, animal welfare, and microbial resistance, increased focus on avian healthcare, and shift from treatment to the prevention of diseases are some of the other factors anticipated to create growth opportunities in the market. For instance, the TAbic Vaccines Line by Phibro Animal Health Corporation comprises 25+ vaccines for poultry for protection against Newcastle disease, infectious bronchitis, and other poultry diseases.

Poultry Vaccines Market Report Highlights

  • The increasing prevalence of infectious diseases in poultry and product developments in the field are anticipated to create growth opportunities in the market
  • By product, attenuated live vaccines held the largest revenue share in 2021 owing to their relatively low production cost and long duration of protection
  • The Egg Drop Syndrome (EDS) disease type segment is expected to register a lucrative growth rate over the forecast period due to the growing use of inactivated vaccines to prevent viral disease
  • As per the MSD Vet Manual, EDS vaccines can also be given in combination with other vaccines, such as those for Newcastle disease, thus increasing their adoption rate
  • The breeder application segment dominated the market in 2021 due to the increasing use of vaccines at breeder farms to secure the health of the poultry and increase farm’s productivity
  • Europe held the largest revenue share in 2021 due to favorable government policies, rising concerns of zoonoses, and initiatives by key companies
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 Objectives
Chapter 2 Executive Summary
2.1 Poultry Vaccines Market Summary
Chapter 3 Poultry Vaccines Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping, 2021
3.3 Poultry Vaccines Market Dynamics
3.3.1 Market driver analysis
3.3.2 Market restraint analysis
3.3.3. Market opportunity analysis
3.3.4. Market challenge analysis
3.4 Poultry Vaccines Market Analysis Tools: Porters
3.4.1 Supplier Power
3.4.2. Buyer Power
3.4.3. Substitution Threat
3.4.4. Threat of New Entrants
3.4.5. Competitive Rivalry
3.5 Poultry Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6. Regulatory Landscape
Chapter 4 COVID-19 Impact Analysis
4.1 COVID-19 Prevalence Analysis
4.2. Current Impact & Future Scenario
4.3. Impact on Market Players
Chapter 5 Poultry Vaccines Market: Segment Analysis, By Application, 2017 - 2030 (USD Million)
5.1 Application Market Share Analysis, 2021 & 2030
5.2 Poultry Vaccines market, by Application, 2017 to 2030
5.3 Broiler
5.3.1 Broiler market, 2017 - 2030 (USD Million)
5.4 Layer
5.4.1 Layer market, 2017 - 2030 (USD Million)
5.5 Breeder
5.5.1 Breeder market, 2017 - 2030 (USD Million)
Chapter 6 Poultry Vaccines Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)
6.1 Product Market Share Analysis, 2021 & 2030
6.2 Poultry Vaccines market, by Product, 2017 to 2030
6.3 Attenuated Live Vaccines
6.3.1 Attenuated Live Vaccines market, 2017 - 2030 (USD Million)
6.4 Inactivated Vaccines
6.4.1 Inactivated Vaccines market, 2017 - 2030 (USD Million)
6.5 Subunit Vaccines
6.5.1 Subunit Vaccines market, 2017 - 2030 (USD Million)
6.6 DNA Vaccines
6.6.1 DNA Vaccines market, 2017 - 2030 (USD Million)
6.7 Recombinant Vaccines
6.7.1 Recombinant Vaccines market, 2017 - 2030 (USD Million)
Chapter 7 Poultry Vaccines Market: Segment Analysis, By Disease Type, 2017 - 2030 (USD Million)
7.1 Disease Type Market Share Analysis, 2021 & 2030
7.2 Poultry Vaccines Market, by Disease Type, 2017 to 2030
7.3 Infectious Bronchitis
7.3.1 Infectious Bronchitis market, 2017 - 2030 (USD Million)
7.4 Infectious Bursal Diseases
7.4.1 Infectious Bursal Diseases market, 2017 - 2030 (USD million)
7.5 Infectious Laryngotracheitis
7.5.1 Infectious Laryngotracheitis market, 2017 - 2030 (USD Million)
7.6 Egg Drop Syndrome
7.6.1 Egg Drop Syndrome market, 2017 - 2030 (USD Million)
7.7 Adenovirus
7.7.1 Adenovirus market, 2017 - 2030 (USD Million)
7.8 Duck Viral Enteritis
7.8.1 Duck Viral Enteritis market, 2017 - 2030 (USD Million)
7.9 Inclusion Body Hepatitis
7.9.1 Inclusion Body Hepatitis market, 2017 - 2030 (USD Million)
7.10 Coccidiosis
7.10.1 Coccidiosis market, 2017 - 2030 (USD Million)
7.11 Avian Influenza
7.11.1 Avian Influenza market, 2017 - 2030 (USD Million)
7.12 Marek's Disease
7.12.1 Marek's Disease market, 2017 - 2030 (USD Million)
7.13 Newcastle Disease
7.13.1 Newcastle Disease market, 2017 - 2030 (USD Million)
7.14 Salmonella
7.14.1 Salmonella market, 2017 - 2030 (USD Million)
7.15 Avian Encephalomyelitis
7.15.1 Avian Encephalomyelitis market, 2017 - 2030 (USD Million)
7.16 Fowl Cholera
7.16.1 Fowl Cholera market, 2017 - 2030 (USD Million)
Chapter 8 Poultry Vaccines Market: Regional Market Analysis 2017 - 2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Movement Analysis, 2021 & 2030
8.3 Regional Market Snapshot
8.4 North America
8.4.1 North America Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1 U.S. Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.4.3 Canada
8.4.3.1 Canada Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.5 Europe
8.5.1 Europe Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.5.2 U.K.
8.5.2.1 U.K. Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.5.3 Germany
8.5.3.1 Germany Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.5.4 France
8.5.4.1 France Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.5.5 Italy
8.5.5.1 Italy Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.5.6 Spain
8.5.6.1 Spain Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.5.7 Russia
8.5.7.1 Russia Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Poultry Vaccines market, 2017 - 2030 (USD Million)
8.6.2 Japan
8.6.2.1 Japan Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.6.3 China
8.6.3.1 China Poultry Vaccines Market, 2017 - 2030 (USD million)
8.6.4 India
8.6.4.1 India Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.6.5 Australia
8.6.5.1 Australia Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.7 Latin America
8.7.1 Latin America Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.8 MEA
8.8.1 MEA Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa Poultry Vaccines Market, 2017 - 2030 (USD Million)
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia Poultry Vaccines Market, 2017 - 2030 (USD Million)
Chapter 9 Poultry Vaccines Market - Competitive Analysis
9.1 Market Participant Categorization
9.1.1. Company Market Position Analysis
9.1.2. Synergy Analysis: Major Deals & Strategic Alliances
9.1.3. Market Leaders
9.1.4. Innovators
9.2. List of Key Companies
Chapter 10 Poultry Vaccines Market - Company Profiles
10.1 Boehringer Ingelheim International GmbH
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 Ceva
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Zoetis
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 Elanco
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 Intervet Inc., a Subsidiary of Merck & Co., Inc.
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Hester Biosciences Limited
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 Vaxxinova International BV
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Venkys India
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 Calier
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 KM Biologics
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.10.4 Strategic initiatives
10.11 Phibro Animal Health Corporation
10.11.1 Company overview
10.11.2 Financial performance
10.11.3 Product benchmarking
10.11.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings